CLLS Competitors & Alternatives
Compare Cellectis SA with similar stocks in the same industry
Biotechnology
CLLS
Main Stock$3.09
Tradestie Score
52
Market Cap
$330.07M
Revenue Growth
-0.4%
Analyst Upside
+146.0%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$25.80
|
$357.51M | - | 55 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.70
|
$354.45M | - | 49 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$28.42
|
$353.70M | - | 56 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.64
|
$350.98M | - | 51 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.61
|
$341.56M | - | 55 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.71
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$8.88
|
$328.62M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.56
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.34
|
$297.23M | - | 50 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.28
|
$293.03M | - | 56 | Compare |
More CLLS Analysis
Data updated: Jun 13, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry